Sven Dethlefs
PureTech Health | Boston
- Role
- CEO Celea Therapeutics at Puretech Health
- Location
- Philadelphia, PA, US
- LinkedIn followers
- 500 followers
About Sven Dethlefs
Global pharmaceutical executive with over 25 years of experience. CEO of Celea Therapeutics. Transformative leadership in executive roles at Teva Pharmaceuticals. Partner at McKinsey & Company. Geographic experience: North America, Europe, International Markets (Latam, China, Japan, Korea)Industry coverage: Innovative medicines, Biosimilars, Gx and OTC
Experience
CEO Celea Therapeutics
Aug 2025 — Present
Celea Therapeutics is a PureTech Health portfolio company focused on the development of new treatments for patients with severe respiratory diseases. Its lead program is Deupirfenidone.
Education
University of Tübingen
Biochemistry
1989 — 1990
Fondazione IRCCS Istituto Neurologico Carlo Besta Milan | Italy
Research Fellow Molecular Biology
1993 — 1994
Freie Universität Berlin
Dr.rer.nat/PhD, Biochemistry
1990 — 1997
Institute Pasteur Paris | France
PhD Research Immunology
1994 — 1997
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.